Oracle Falls 8.5% on June 12; UBS Says Market Overreacting to CapEx Concerns

According to UBS analysts, Oracle (ORCL) stock fell 8.5% on June 12, with the bank viewing the sell-off as an overreaction to capital expenditure concerns rather than deteriorating fundamentals. UBS noted that Oracle's fourth-quarter results beat or matched expectations, and first-quarter revenue guidance exceeded the bank's forecast. The company also reaffirmed multi-year revenue and earnings-per-share growth targets, signaling management confidence in long-term business prospects.

The market's pressure stems from Oracle's capital expenditure guidance exceeding consensus estimates. However, UBS argued the reaction is too severe, as the company is simultaneously expanding compute capacity, securing new orders, and benefiting from cost savings through headcount reductions. Despite increased investments and new business momentum, Oracle maintained its full-year guidance, which UBS interprets as a positive signal on future operational prospects.